Penumbra PEN Stock
Penumbra Price Chart
Penumbra PEN Financial and Trading Overview
| Penumbra stock price | 319.37 USD |
| Previous Close | 318.3 USD |
| Open | 318.41 USD |
| Bid | 318.45 USD x 4000 |
| Ask | 318.63 USD x 8000 |
| Day's Range | 317.81 - 320.75 USD |
| 52 Week Range | 221.26 - 362.41 USD |
| Volume | 267.1K USD |
| Avg. Volume | 543.86K USD |
| Market Cap | 12.53B USD |
| Beta (5Y Monthly) | 0.735 |
| PE Ratio (TTM) | 73.55196 |
| EPS (TTM) | 4.33 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 363.36 USD |
PEN Valuation Measures
| Enterprise Value | 12.12B USD |
| Trailing P/E | 73.55196 |
| Forward P/E | 50.57727 |
| PEG Ratio (5 yr expected) | 0.74 |
| Price/Sales (ttm) | 8.613366 |
| Price/Book (mrq) | 8.751615 |
| Enterprise Value/Revenue | 8.334 |
| Enterprise Value/EBITDA | 59.421 |
Trading Information
Penumbra Stock Price History
| Beta (5Y Monthly) | 0.735 |
| 52-Week Change | 24.25% |
| S&P500 52-Week Change | 27.69% |
| 52 Week High | 362.41 USD |
| 52 Week Low | 221.26 USD |
| 50-Day Moving Average | 328.27 USD |
| 200-Day Moving Average | 303.41 USD |
PEN Share Statistics
| Avg. Volume (3 month) | 543.86K USD |
| Avg. Daily Volume (10-Days) | 459.19K USD |
| Shares Outstanding | 39.33M |
| Float | 38.23M |
| Short Ratio | 3.92 |
| % Held by Insiders | 2.92% |
| % Held by Institutions | 87.94% |
| Shares Short | 1.92M |
| Short % of Float | 5.59% |
| Short % of Shares Outstanding | 4.86% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 11.76% |
| Operating Margin (ttm) | 10.20% |
| Gross Margin | 67.38% |
| EBITDA Margin | 14.02% |
Management Effectiveness
| Return on Assets (ttm) | 6.69% |
| Return on Equity (ttm) | 12.73% |
Income Statement
| Revenue (ttm) | 1.45B USD |
| Revenue Per Share (ttm) | 37.2 USD |
| Quarterly Revenue Growth (yoy) | 15.59% |
| Gross Profit (ttm) | 979.96M USD |
| EBITDA | 203.96M USD |
| Net Income Avi to Common (ttm) | 171.05M USD |
| Diluted EPS (ttm) | 4.33 |
| Quarterly Earnings Growth (yoy) | -16.90% |
Balance Sheet
| Total Cash (mrq) | 615.66M USD |
| Total Cash Per Share (mrq) | 15.65 USD |
| Total Debt (mrq) | 216.18M USD |
| Total Debt/Equity (mrq) | 14.67 USD |
| Current Ratio (mrq) | 6.024 |
| Book Value Per Share (mrq) | 36.391 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 276.66M USD |
| Levered Free Cash Flow (ttm) | 141.8M USD |
Profile of Penumbra
| Country | United States |
| State | CA |
| City | Alameda |
| Address | One Penumbra Place |
| ZIP | 94502 |
| Phone | 510 748 3200 |
| Website | https://www.penumbrainc.com |
| Industry | Medical Devices |
| Sector(s) | Healthcare |
| Full Time Employees | 4700 |
Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.
Q&A For Penumbra Stock
What is a current PEN stock price?
Penumbra PEN stock price today per share is 319.37 USD.
How to purchase Penumbra stock?
You can buy PEN shares on the NYSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Penumbra?
The stock symbol or ticker of Penumbra is PEN.
Which industry does the Penumbra company belong to?
The Penumbra industry is Medical Devices.
How many shares does Penumbra have in circulation?
The max supply of Penumbra shares is 39.33M.
What is Penumbra Price to Earnings Ratio (PE Ratio)?
Penumbra PE Ratio is 73.75751000 now.
What was Penumbra earnings per share over the trailing 12 months (TTM)?
Penumbra EPS is 4.33 USD over the trailing 12 months.
Which sector does the Penumbra company belong to?
The Penumbra sector is Healthcare.
Penumbra PEN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NYSE Composite Index NYA | 23276.49 USD — |
-0.87
|
— — | — — | — — | — - | — — |
| US Tech DM Ex Japan Large Mid Ca NQDMXJPLMAUD | 2100.38 AUD 1390.15 USD |
<0.01
|
— — | 2100.38 AUD 1390.15 USD | 2100.38 AUD 1390.15 USD | — - | — — |
| US Tech CB Insights Metaverse US NYMETA | 2029.46 USD — |
-0.82
|
— — | 2022.34 USD — | 2053.13 USD — | — - | — — |
| US Tech AlphaDEX Multi Cap Growt NQDXUSMLTCG | 4054.02 USD — |
-0.25
|
— — | 4019.75 USD — | 4077 USD — | — - | — — |
- {{ link.label }} {{link}}


